SUMITOMO CHEMICAL COMPANY, LIMITED (4005) Stock Price

Market cap
¥879.3B
P/E ratio
15.8x
A Japanese chemical company that makes everything from pesticides and fertilizers to smartphone components and pharmaceuticals, serving industries worldwide.

Price and Volume

Market Cap

Subscribe to premium to access
Market Cap.

Check pricing

PER

Subscribe to premium to access
PER.

Check pricing

PBR

Business Overview

Sumitomo Chemical operates across multiple business segments, providing a diverse range of products and services.

1. **Agro & Life Solutions**

This segment manufactures and sells pesticides, fertilizers, agricultural materials, household and pest control insecticides, tropical disease prevention materials, and feed additives. Key affiliated companies include Valent U.S.A. Corporation and Sumitomo Chemical Brasil Indústria Química S.A.

2. **ICT & Mobility Solutions**

This segment manufactures and sells optical products, semiconductor process materials, compound semiconductor materials, touch sensor panels, high-purity aluminum and alumina, chemical products, additives, engineering plastics, and battery materials. Affiliated companies include Dongyou Fine Chem Co., Ltd. and Sumika Semiconductor Materials Texas Incorporated.

3. **Advanced Medical Solutions**

This segment operates CDMO (contract development and manufacturing) services in small-molecule pharmaceuticals, medical oligonucleotides, and regenerative and cell-based therapeutics. Koei Chemical Co., Ltd. is a principal affiliated company.

4. **Essential & Green Materials**

This segment manufactures and sells synthetic resins, synthetic fiber raw materials, industrial chemicals, methacrylic products, processed synthetic resin products, standard aluminum and alumina, and synthetic rubber. Affiliated companies include Japan Singapore Petrochemical Co., Ltd. and The Polyolefin Company (Singapore) Private Limited.

5. **Sumitomo Pharma**

This segment manufactures and sells small-molecule pharmaceuticals. Affiliated companies include Sumitomo Pharma Co., Ltd. and Sumitomo Pharma America Incorporated.

6. **Other**

This segment provides radioactive diagnostic agents, electricity and steam supply, chemical plant design and construction supervision, and transportation and warehousing services. Sumitomo Seika Chemicals Co., Ltd. is a principal affiliated company.

Through these diverse business operations, Sumitomo Chemical contributes to a wide range of industries.

Management Policy

Sumitomo Chemical recorded a core operating loss of 149 billion yen in fiscal 2023 due to margin deterioration in petrochemical-related businesses and the impact of patent expiration at Sumitomo Pharma under its 2022-2024 medium-term management plan. However, through intensive short-term performance improvement measures and structural reforms, the company achieved a V-shaped recovery with core operating profit of 140.5 billion yen in fiscal 2024.

The company positions itself as an "Innovative Solution Provider" for the long term, leveraging its technological and business strengths to address four social challenges: "Food," "ICT," "Healthcare," and "Environment." In October 2024, the company reorganized its business divisions to provide innovative solutions addressing these challenges.

Under its 2025-2027 medium-term management plan, the company adopts "Leap Beyond" as its slogan, concentrating management resources in the Agro & Life and ICT & Mobility domains. The company will pursue ROIC-focused management to improve profitability and capital efficiency, targeting core operating profit of 200 billion yen, ROE of 8%, and ROIC of 6% by fiscal 2027.

Sumitomo Chemical is advancing its business portfolio sophistication, positioning Agro & Life and ICT & Mobility as growth drivers while developing Advanced Medical as a future pillar. In Essential & Green Materials, the company will promote environmental burden reduction initiatives to achieve sustainable growth.

The company is advancing structural reforms at Petro Rabigh and Sumitomo Pharma to strengthen business resilience. Furthermore, the company will reinforce ROIC-focused management and improve its financial position to pursue sustained corporate value enhancement. From 2030 onward, the company aims to become a globally prominent enterprise by adding healthcare and environmental solutions.

AI Chat